Researchers develop rapid COVID-19 test to identify variants in hours
Access to restricted content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in the following ways:Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.
Shibboleth / Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.Select your institution from the list provided, which will take you to your institution's website to sign in. When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.Enter your library card number to sign in. If you cannot sign in, please contact your librarian.Many societies offer member access to their journals using single sign-on between the society website and Oxford Academic.
For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.You can be signed in to your personal account and your institution’s account at the same time. Click the account icon in the top left to view your signed in accounts and access account management features.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The antiviral effects of thiol drugs in COVID-19The antiviral effects of thiol drugs in COVID-19 APSPhysiology UCSFHospitals COVID19 antiviral coronavirus covid
Read more »
Acute cardiac side effects after COVID-19 mRNA vaccination: a case series - European Journal of Medical ResearchBackground Vaccination against SARS-CoV-2 has been the main tool to contain the pandemic. The rush development of the 3 vaccines and their expedited approval have led to inoculation of millions of patients around the world, leading to a containment of the disease. Despite continuous viral mutations and the identification of weaker variants, the severity of the infections has been mild, with many patients being either asymptomatic or recovering at home. Currently the focus has shifted from the host of organ damage related to the infection to potential side effects of the vaccine. Myocarditis has been reported as one of the potential side effects from the mRNA vaccine, affecting young healthy individuals. Up to September 30, 2021, 1.243 cases of myocarditis after vaccination with BNT162b2 Comirnaty© were registered in young adults by the Paul-Ehrlich-Institute in Germany alone. The exact pathophysiology and the risk factors for myocarditis following vaccination remain unclear. We present a case series of eight patients with cardiac symptom shortly after SARS-CoV-2 mRNA vaccination (BNT162b6, Biontech, Comirnaty© or mRNA-1237 Moderna, Spikevax©). Patients and methods Eight patients between 13 and 56 years of age, vaccinated with either BNT162b2 or mRNA-1273 mRNA vaccine between January and August 2021 developed cardiac side effects shortly after either their first or second dose of the vaccine. Clinical data were retrieved from the clinical information system and analyzed. To support diagnosis of myocarditis or pericarditis, cardiac magnetic resonance imaging (MRI) was performed shortly after the onset of symptoms, with further investigations in severe cases. Symptoms were defined as dyspnea, chest pain and cardiac arrhythmia as determined by electrocardiography. Results Eight patients (5 males and 3 females) developed cardiac symptoms compatible with myocarditis, according to the CDC criteria, shortly after SARS-CoV-2 mRNA vaccination. Three patients (2 males, 1 femal
Read more »
Herpesvirus and neurological manifestations in patients with severe coronavirus disease - Virology JournalBackground Certain clinical manifestations of coronavirus disease (COVID-19) mimic those associated with human herpesvirus (HHV) infection. In this study, we estimated the prevalence of herpesvirus in patients with COVID-19 and determined if coinfection is associated with poorer outcomes and neurological symptoms. Methods We analyzed samples of 53 patients diagnosed with COVID-19. The samples were evaluated for the presence of alphaherpesviruses, betaherpesviruses, and gammaherpesviruses, and the viral loads were quantified using quantitative polymerase chain reaction (qPCR) method. Results Among the patients, in 79.2% had detection at least one type of herpesvirus. HHV-6 (47.2%), cytomegalovirus (43.3%), and HHV-7 (39.6%) showed the highest detection rates. Patients with a high severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) load were more likely to show herpes simplex virus 1 detection (p = 0.037). Among patients coinfected with SARS-CoV-2 and HHVs, 26.4% showed central nervous system-associated neurological symptoms and herpetic manifestations. A statistically significant association was observed between neurological changes and HHV-6 detection (p = 0.034). Conclusions The findings showed a high prevalence of herpesvirus in patients with COVID-19. Furthermore, even though SARS-CoV-2 and HHV coinfection was not associated with poorer outcomes, the findings demonstrated the association between neurological symptoms and HHV-6 detection.
Read more »
Covid infections jump by half a million in UK, says ONSThe rise is being driven by two new sub-variants of Omicron which are spreading quickly.
Read more »
Land secured for Gainsborough's first multiplex cinemaThere will be a 4-screen cinema, two retail units, a restaurant, and additional parking Gainsborough
Read more »
Uniformed police told not to march at London Pride by organisersOrganisers say there are real concerns within the LGBTQ+ community about 'police homophobia'.
Read more »